Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months; -20℃ 1 month
研究领域：
Neurological Disease
Target：
IC50: 1.75 μM (APJ, cell-based)[1]
描述：
ML221 is a potent apelin (APJ) functional antagonist, inhibiting apelin-13-mediated activation of APJ, with IC50s of 0.70 μM in the cAMP assay, and 1.75 μM in the β-arrestin assay, and EC80 of 10 nM i
